Drug
Verubulin clinical trials
Also written MPC-6827 and Azixa.
- studies test it
- 7
- open now
- 0
- in phase 3
- 0
- first study started
- 2005
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2005 (2)
| Year | Studies |
|---|---|
| 2005 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 1
Myrexis Inc. (6) · Columbia University (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Antimitotic Agents source
Studies
Open first, then newest update. How each study uses verubulin is read from its arms, and is right about nine times in ten.
Testing it · 7
- Exploratory Evaluation of [11C]MPC6827CompletedEarly Phase 1Columbia UniversityNCT04575727Written as [11C]MPC6827
- Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma MultiformeCompletedPhase 2Myrexis Inc.NCT01285414Written as Verubulin
- Phase 2 Study MPC-6827 for Recurrent Glioblastoma MultiformeCompletedPhase 2Myrexis Inc.NCT00892931Written as Azixa
- Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma MultiformeStatus unknownPhase 1/2Myrexis Inc.NCT00635557Written as MPC-6827 + Carboplatin
- Phase 1 Study of MPC-6827 and Temozolomide in Metastatic MelanomaCompletedPhase 1/2Myrexis Inc.NCT00609011Written as MPC-6827 + Temozolomide
- Multiple Dose Study of MPC-6827 in Subjects With Refractory Brain MetastasesCompletedPhase 1Myrexis Inc.NCT00393965Written as MPC-6827
- Phase 1, Multiple Dose Study of MPC-6827 in Subjects With Refractory Solid TumorsCompletedPhase 1Myrexis Inc.NCT00394446Written as MPC-6827
Codes
What other systems call verubulin · ClinicalTrials.gg INT005160
- MeSH (NLM) C522974verubulinOne source NLM
- UNII (FDA) X97O9FTB92VERUBULINConfirmed FDA, NLM, Wikidata
- Wikidata Q27293718verubulinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C96747VerubulinOne source FDA
- DrugBank DB05585One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C522974 | verubulin | One source NLM |
| UNII (FDA) | X97O9FTB92 | VERUBULIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27293718 | verubulin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C96747 | Verubulin | One source FDA |
| DrugBank | DB05585 | — | One source Wikidata |
Also registered as verubulin hydrochloride (UNII 33380QZ0QW).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.